Orthofix Medical Inc (OFIX)
Orthofix Medical Inc. is a healthcare company listed on NASDAQ as common stock. Through its subsidiaries, the company develops, manufactures, and markets medical technology products in the United States and internationally, including operations in Italy, the United Kingdom, France, Germany, and Brazil. Its business is organized into two segments: Global Spine and Global Limb Reconstruction. The Global Spine segment focuses on bone growth stimulation devices, spinal fixation implants, bone graft substitutes, navigation technologies, and the 7D FLASH Navigation System for spinal and cranial procedures. The Global Limb Reconstruction segment serves deformity correction, limb lengthening, fracture management, and limb preservation with external and internal fixation products supported by digital technologies. Orthofix sells through distributors and sales representatives to hospitals, healthcare organizations, physicians, ambulatory surgery centers, and outpatient hospitals. The company was founded in 1980 and is headquartered in Lewisville, Texas.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-OFIX
|
$15.46
|
32.5% Upside
|
Undervalued
|
$15.50
|
32.8% Upside
|
Undervalued
|
Good
|
—
|
—
|
—
|
0.0%
|
August 5, 2026
|
-7.8x
|
1.1x
|
0.6x
|
467.3 M
|
612.1 M
|
35.9%
|
99.2%
|
1.4
|
—
|
7.4%
|
